store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zardaverine (BY 290) 是一种可口服且具有选择性和有效性的 PDE3/4 抑制剂 ,具有支气管扩张活性和抗肝癌活性。Zardaverine 在血小板中的作用是通过PDE III同工酶介导,可用于研究急性肾衰竭呵呵慢性气流阻塞。
产品描述 | Zardaverine (BY 290) is an orally available, selective and potent PDE3/4 inhibitor with bronchodilator activity and anti-hepatocarcinogenic activity.Zardaverine's action in platelets is mediated by PDE III isoenzymes and can be used in studies of acute renal failure and chronic airflow obstruction. |
体外活性 | Zardaverine selectively inhibits the growth of human hepatocellular carcinoma (HCC) cells in vitro when administered at concentrations ranging from 0 to 30 µM for 72 hours[3].Selective antitumor activity of Zardaverine is observed, closely related to the regulation of cell cycle-associated proteins, but independent of PDE3/4 inhibition[3].At a concentration of 0.1 µM for 24 hours, Zardaverine selectively induces G0/G1-phase arrest and dysregulates cell cycle-associated proteins in HCC cells[3].Zardaverine induces apoptosis in a time- and concentration-dependent manner in Bel-7402 and SMMC-7721 cells. The concentrations used include 0.01, 0.03, 0.1, 0.3, and 1 µM over 48 hours, as well as 0.3 and 1 µM over 24, 36, 48, 60, and 72 hours[3]. |
别名 | BY 290, B 84290 |
分子量 | 268.22 |
分子式 | C12H10F2N2O3 |
CAS No. | 101975-10-4 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 20 mg/mL (74.57 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.7283 mL | 18.6414 mL | 37.2828 mL | 93.2071 mL |
5 mM | 0.7457 mL | 3.7283 mL | 7.4566 mL | 18.6414 mL | |
10 mM | 0.3728 mL | 1.8641 mL | 3.7283 mL | 9.3207 mL | |
20 mM | 0.1864 mL | 0.9321 mL | 1.8641 mL | 4.6604 mL | |
50 mM | 0.0746 mL | 0.3728 mL | 0.7457 mL | 1.8641 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Zardaverine 101975-10-4 Metabolism PDE BY 290 B 84290 Inhibitor inhibitor inhibit